MedPath

Prostate Impendance Test Project

Conditions
Prostatic Neoplasms
PSA
Prostatic Biopsy
Impedance Test
Registration Number
NCT03428087
Lead Sponsor
University of Pisa
Brief Summary

Impedance-based analysis could provide an adequate response to the need to identify a safe and reliable tool alternative to bioptic diagnosis. Patients who are candidates for prostate biopsy as suffering from urinary symptoms accompanied by clinical suspicions such as high total PSA value and / or presence of prostate nodule and / or evidence of obvious lesion to available imaging methods will be subjected to impedance measurement. Aim of this study is to be able to structure a bivariate analysis of the distribution of impedances detected in patients with neoplasia in order to detect test median reference values.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
100
Inclusion Criteria
  1. age> 45 years
  2. up of total PSA values beyond the normal range (> 4 ng / ml)
  3. presence or absence of suspicious prostate nodule
Exclusion Criteria
  1. previous history of cancer
  2. BMI>30
  3. patients with previous diagnosis of PIN HG at prostate core biopsy or in active surveillance

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impedance-based analysis based on phase-sensitive sensorsduring rectal examination
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AOUP Ospedale cisanello

🇮🇹

Pisa, Toscana, Italy

© Copyright 2025. All Rights Reserved by MedPath